Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Fernando

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Acta Anaesthesiologica Scandinavica|January 26, 2018
Morphine and pholcodine-specific IgE have limited utility in the diagnosis of anaphylaxis to benzylisoquinolinesM A Rose, J Anderson, S L Green, et al.
Novartis Foundation Symposium|May 31, 2007
The genetic control of susceptibility to Mycobacterium tuberculosisW J Britton, S L Fernando, B M Saunders, et al.
HLA|September 9, 2017
A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactionsD V Nguyen, C Vidal, H C Chi, et al.
The Journal of Infection|April 27, 2025
Development and validation of a cephalosporin allergy clinical decision ruleF Cox, S Vogrin, R P Sullivan, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Acta Anaesthesiologica Scandinavica|January 26, 2018
Morphine and pholcodine-specific IgE have limited utility in the diagnosis of anaphylaxis to benzylisoquinolinesM A Rose, J Anderson, S L Green, et al.
Novartis Foundation Symposium|May 31, 2007
The genetic control of susceptibility to Mycobacterium tuberculosisW J Britton, S L Fernando, B M Saunders, et al.
HLA|September 9, 2017
A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactionsD V Nguyen, C Vidal, H C Chi, et al.
The Journal of Infection|April 27, 2025
Development and validation of a cephalosporin allergy clinical decision ruleF Cox, S Vogrin, R P Sullivan, et al.
Pageof 2